跳至主要内容
临床试验/NCT05632770
NCT05632770进行中(未招募)不适用

A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Targeting PTSD and Comorbidity for Acutely Hospitalized Injury Survivors Treated in US Trauma Care Systems

University of Washington2 个研究点 分布在 1 个国家目标入组 424 人开始时间: 2023年1月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
424
试验地点
2
主要终点
Emergency department utilization change over time

研究概览

简要总结

This investigation is a randomized pragmatic trial of a brief stepped care intervention delivered from an acute care medical trauma center that may both reduce the symptoms of posttraumatic stress disorder (PTSD) and diminish emergency department health service utilization.

详细描述

Life-threatening traumatic exposures requiring presentation to acute care medical settings are endemic in the US in the era of the COVID-19 pandemic, firearm proliferation, and extreme weather events, and constitute both a substantial source of individual suffering and a significant public health burden. Each year in the US, over 30 million individuals present to acute care medical settings after injury, and approximately 2.5 million individuals are so severely injured that they require inpatient hospital admissions. The overarching goal of the Trauma Survivors Outcomes and Support (TSOS) investigation is to advance the sustainable delivery of high quality trauma center mental health screening, intervention and referral procedures for diverse injury survivors. Over the past two decades, the TSOS study team that includes research scientists, trauma surgical policymakers, patients, and frontline clinicians has established a track record of using evidence derived from NIH pragmatic trials to directly target American College of Surgeons Committee on Trauma (College) regulatory policy. The TSOS investigation will refine and test optimal stepped care intervention strategies for diverse injury survivors presenting to acute care medical settings with PTSD and associated comorbidity. This single trauma center site pragmatic trial investigation will individually randomize 424 patients (212 intervention and 212 control) to a brief stepped care intervention versus College required screening and referral control conditions. The stepped care intervention consists of proactive care management, as well as medications and psychotherapy elements targeting PTSD and comorbidity. Blinded follow-up interviews at 1-, 3-, 6-, and 12-months post-injury will assess the symptoms of PTSD and related comorbidity for all patients. The emergency department health information exchange will be used to capture population-level automated emergency department/inpatient utilization data for the intent-to-treat sample. The investigation aims to test the primary hypotheses that intervention patients will demonstrate significant reductions in PTSD symptoms and emergency department/inpatient utilization when compared to control patients. The investigation will also explore mediators and moderators of intervention treatment effects that directly address actionable national trauma center quality improvements. A mixed method Rapid Assessment Procedure-Informed Clinical Ethnography (RAPICE) implementation process assessment will facilitate the integration of study results into national College policy requirements, guidelines, and verification criteria. A national trauma center survey will elucidate the progression of PTSD and comorbidity screening, intervention and referral for all US level I and II trauma centers. An end-of-study College policy summit will harness pragmatic trial data to inform the capacity for US trauma centers to implement high quality acute care medical mental health services for diverse patient populations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Injured patients ≥18 years of age
  • Meet ≥ 3 of 10 risk domain criteria in electronic health records (EHR) screen
  • Score of ≥ 30 on DSM-5 PTSD Checklist (PCL) score or score of ≥ 35 on DSM-IV PTSD Checklist (PCL) .
  • Speak English and/or Spanish

排除标准

  • Not admitted for a traumatic injury
  • Speak a language other than English and/or Spanish
  • Acutely suicidal/admitted for a suicide attempt
  • Cognitively impaired
  • Incarcerated
  • Acutely psychotic
  • Not a resident of Washington, California, Alaska, Oregon, Idaho, Montana, or Nevada
  • Less than 2 pieces of contact information
  • Prior history of violence, such that study staff may not be safe
  • Patient with overwhelming psychiatric distress and not advisable/will not tolerate randomization to control condition
  • Most recent COVID-19 test positive

研究组 & 干预措施

Stepped Collaborative Care (Intervention)

Experimental

Patients in the intervention condition will receive a stepped collaborative care intervention that includes posttraumatic concern elicitation, proactive care management, medication, and psychotherapy elements targeting posttraumatic stress disorder (PTSD) and related comorbidity.

干预措施: Stepped Collaborative Care (Behavioral)

American College of Surgeons (ACS) Required Screening and Referral (Usual Care)

Active Comparator

Patients in the control condition will receive usual trauma center care with American College of Surgeons (ACS) required psychosocial screening and referral.

干预措施: American College of Surgeons (ACS) Required Screening and Referral (Usual Care) (Behavioral)

结局指标

主要结局

Emergency department utilization change over time

时间窗: Baseline injury admission to 12-months post-injury follow-up

Number of emergency visits will be assessed using the Emergency Department Information Exchange (EDIE). More emergency visits are indicative of a worse outcome.

Posttraumatic Stress Disorder (PTSD) symptoms change over time

时间窗: Change in symptoms at baseline injury admission and 1-, 3-, 6-, and 12-months post-injury follow-up

The investigators will use the DSM-5 PTSD Checklist (PCL-5) and DSM-IV PTSD Checklist (PCL-IV). The scoring of the PCL-5 scale ranges from a minimum of 0 to a maximum of 80, with higher scores indicating a worse outcome. The measure can also provide a rating of symptoms consistent with a diagnosis of PTSD.

次要结局

  • Depression symptoms change over time(Change in symptoms at baseline injury admission and 1-, 3-, 6-, and 12-months post-injury follow-up)
  • Substance use change over time(Change in symptoms at baseline injury admission and 1-, 3-, 6-, and 12-months post-injury follow-up)
  • Mental and physical functioning change over time(Change in symptoms at baseline injury admission and 1-, 3-, 6-, and 12-months post-injury follow-up)
  • Suicide risk assessment change over time(Change in symptoms at baseline injury admission and 1-, 3-, 6-, and 12-months post-injury follow-up)
  • Alcohol use change over time(Change in symptoms at baseline injury admission and 1-, 3-, 6-, and 12-months post-injury follow-up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Douglas Zatzick

Professor, Psychiatry & Behavioral Sciences

University of Washington

研究点 (2)

Loading locations...

相似试验

招募中
不适用
Specialized Healthcare Service for BPD Patients: Athens TrialOther Mental Conditions
NCT06392139Ioannis A. Malogiannis156
已完成
不适用
Using Practice Facilitation and Operationalizing Referral Information Technology to Increase DSMES UtilizationDiabetes
NCT05472142Mary Lacy22
已完成
不适用
A Clinician-Focused Nudging Intervention to Optimize Post-Surgical PrescribingOpioid PrescribingSurgical Procedure, Unspecified
NCT05299528Vanderbilt University Medical Center240
已完成
不适用
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)Febrile NeutropeniaStage 0 Breast CancerStage 0 Colorectal CancerStage 0 Non-Small Cell Lung CancerStage I Colorectal CancerStage IA Breast CancerStage IA Non-Small Cell Lung CarcinomaStage IB Breast CancerStage IB Non-Small Cell Lung CarcinomaStage IIA Breast CancerStage IIA Colorectal CancerStage IIA Non-Small Cell Lung CarcinomaStage IIB Breast CancerStage IIB Colorectal CancerStage IIB Non-Small Cell Lung CarcinomaStage IIC Colorectal CancerStage IIIA Breast CancerStage IIIA Colorectal CancerStage IIIA Non-Small Cell Lung CancerStage IIIB Breast CancerStage IIIB Colorectal CancerStage IIIB Non-Small Cell Lung CancerStage IIIC Breast CancerStage IIIC Colorectal CancerStage IV Breast CancerStage IV Non-Small Cell Lung CancerStage IVA Colorectal CancerStage IVB Colorectal Cancer
NCT02728596SWOG Cancer Research Network3,665
Unknown
不适用
Community-based Personalized Care and QOLAgingDisability or Chronic Disease Leading to Disablement
NCT03263169Windsor-Essex Compassionate Care Community1,100